Apical hypertrophic cardiomyopathy associated with HCV infection
- Authors: Fomin V.V.1, Nikulkina E.N.1, Sedov V.P.1, Girina S.S.1, Doletskiy A.A.1, Moiseev S.V.1, Fomin VV2, Nikulkina EN2, Sedov VP2, Girina SS2, Doletsky AA2, Moiseev SV2
-
Affiliations:
- The first I. M. Sechenov Moscow Medical University
- Issue: Vol 83, No 1 (2011)
- Pages: 59-62
- Section: Editorial
- URL: https://ter-arkhiv.ru/0040-3660/article/view/30795
- ID: 30795
Cite item
Full Text
Abstract
About the authors
Viktor Viktorovich Fomin
Email: fomin_vic@mail.ru
Elena Nikolaevna Nikulkina
Vsevolod Parisovich Sedov
Svetlana Sergeevna Girina
Email: girina_ss@mail.ru <mailto:girina_ss@mail.ru>
Artem Andreevich Doletskiy
Email: artdoletsky@mail.ru
Sergey Valentinovich Moiseev
Email: chnpharm@mtunet.ru
V V Fomin
The first I. M. Sechenov Moscow Medical UniversityThe first I. M. Sechenov Moscow Medical University
E N Nikulkina
The first I. M. Sechenov Moscow Medical UniversityThe first I. M. Sechenov Moscow Medical University
V P Sedov
The first I. M. Sechenov Moscow Medical UniversityThe first I. M. Sechenov Moscow Medical University
S S Girina
The first I. M. Sechenov Moscow Medical UniversityThe first I. M. Sechenov Moscow Medical University
A A Doletsky
The first I. M. Sechenov Moscow Medical UniversityThe first I. M. Sechenov Moscow Medical University
S V Moiseev
The first I. M. Sechenov Moscow Medical UniversityThe first I. M. Sechenov Moscow Medical University
References
- Watkins H., Rosenzweig A., Hwang D.-S. et al. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N. Engl. J. Med. 1992; 326: 1108-1114.
- Thierfelder L., Watkins H., MacRae C. et al. β-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 1994; 77: 701-712.
- Maron B. J., Sato N., Roberts W. C. et al. ACC/ESC Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Eur. Heart J. 2003; 24: 1965-1991.
- Моисеев В. С., Сумароков А. В. Болезни сердца: Руководство для врачей. М.: Универсум паблишинг; 2001. 196- 207.
- Elliott P., McKenna W. J. Hypertrophic cardiomyopathy. Lancet 2004; 363: 1881-1891.
- Попов В. Г., Седов В. П., Груздев А. К., Алушков М. В. Сравнительная клинико-инструментальная характеристика различных морфологических вариантов гипертрофической кардиомиопатии. Кардиология 1985; 5 (5): 14-19.
- Sakamoto T. Apical hypertrophic cardiomyopathy (apical hypertrophy): an overview. J. Cardiol. 2001; 37 (Suppl. 1): 161-178.
- Sakamoto T., Tei C., Murayama M. et al. Giant T wave inversion as a manifestation of asymmetrical apical hypertrophy (AAH) of the left ventricle. Echocardiographic and ultrasono-cardiotomographic study. Jpn Heart J. 1976; 17 (5): 611-629.
- Pillarisetti J., Gupta K. Giant inverted T waves in the emergency department: case report and review of differential diagnoses. J. Electrocardiol. 2010; 43 (1): 40-42.
- Dumont C. A., Monserrat L., Soler R. et al. Interpretation of electrocardiographic abnormalities in hypertrophic cardiomyopathy with cardiac magnetic resonance. Eur. Heart J. 2006; 27 (14): 1725-1731.
- Kitaoka H., Doi Y., Casey S. A. et al. Comparison of prevalence of apical hypertrophic cardiomyopathy in Japan and the United States. Am. J. Cardiol. 2003; 92 (10): 1183-1186.
- Maron B. J. Hypertrophic cardiomyopathy: a systematic review. J. A. M. A. 2002; 287 (10): 1308-1320.
- Ridjab D., Koch M., Zabel M. et al. Cardiac arrest and ventricular tachycardia in Japanese-type apical hypertrophic cardiomyopathy. Cardiology 2007; 107 (2): 81-86.
- Okishige K., Sasano T., Yano K. et al. Serious arrhythmias in patients with apical hypertrophic cardiomyopathy. Intern. Med. 2001; 40 (5): 396-402.
- Carter D., Pokroy R., Barenboim E. et al. Apical hypertrophic cardiomypathy and arrhythmia in military pilots. Aviat. Space Environ. Med. 2006; 77 (4): 459-461.
- Hiasa G., Hamada M., Kodama K. et al. Apical hypertrophic cardiomyopathy associated with life-threatening paroxysmal atrial flutter with a slow ventricular response: a case report. Jpn Circ. J. 2000; 64 (3): 225-228.
- Gavaliatsis I. P., Kouvousis N. M., Rallidis L. S. et al. Recurrent atrial flutter in apical hypertrophic cardiomyopathy. Jpn Heart J. 1992; 33 (4): 499-504.
- Cassimatis D. C., Atwood J. E. Apical hypertrophic cardiomyopathy with giant negative T waves. Mayo Clin. Proc. 2005; 80 (9): 1245.
- Фаез Х. В., Коровина Е. П., Шатковский Н. П. и др. Характеристика кардиомиопатии в различных географических регионах. Клин. мед. 1992; 70 (11-12): 27-30.
- Miyamoto T., Horigome H., Kawamo S., Sumazaki R. Apical hypertrophic cardiomyopathy in childhood: a long-term follow-up report of two cases. Pediatr. Cardiol. 2009; 30 (3): 343-346.
- Shah A., Duncan K., Winson G. et al. Severe symptoms in mid and apical hypertrophic cardiomyopathy. Echocardiography 2009; 26 (8): 922-933.
- Nasermoaddeli A., Miura K., Matsumori A. et al. Prognosis and prognostic factors in patients with hypertrophic cardiomyopathy in Japan: results from a nationwide study. Heart 2007; 93 (6): 711-715.
- Chung T., Yiannikas J., Freedman S. B., Kritharides L. Unusual features of apical hypertrophic cardiomyopathy. Am. J. Cardiol. 2010; 105 (6): 879-883.
- Eriksson M. J., Sonnenberg B., Woo A. et al. Long-term outcome in patients with apical hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 2002; 39 (4): 638-645.
- Kubo T., Kitaoa H., Okawa M. et al. Clinical profiles of hypertrophic cardiomyopathy with apical phenotype. Comparison of pure-apical form and distal-dominant form. Circ. J. 2009; 73: 2330-2336.
- Arad M., Penas-Lado M., Montserrat L. et al. Gene mutations in apical hypertrophic cardiomyopathy. Circulation 2005; 112: 2805-2811.
- Malouf J., Ratl H., Der Kaloustian V. M. Apical hypertrophic cardiomyopathy in a father and daughter. Am. J. Med. Genet. 1985; 22 (1): 75-80.
- Monserrat L., Hermida-Prieto M., Fernandez X. et al. Mutation in the alpha-cardiac actin gene associated with apical hypertrophic cardiomyopathy, left ventricular non-compaction, and septal defects. Eur. Heart J. 2007; 28 (16): 1953- 1961.
- Stöllberger C., Hamedanchi A., Finsterer J. Myopathy, apical hypertrophic cardiomyopathy and left ventricular non-compaction within the same family. Acta Cardiol. 2009; 64 (1): 35-40.
- Kishimoto C., Takada H., Hiraoka Y. et al. HLA-DR2 antigen linkage in patients with apical hypertrophic cardiomyopathy in Japan. Cardiology 1996; 76 (6): 488-491.
- Date M., Otsu K., Nishida K. et al. Single-strand conformation polymorphism analysis on the delta-sarcoglycan gene in Japanese patients with hypertrophic cardiomyopathy. Am. J. Cardiol. 2000; 85 (11): 1315-1318.
- Shichi D., Matsumori A., Naruse T. K. et al. HLA-DPbeta chain may confer the susceptibility to hepatitis C virus-associated hypertrophic cardiomyopathy. Int. J. Immunogenet. 2008; 35 (1): 37-43.
- Matsumori A., Ohashi N., Hasegawa K. et al. Hepatitis C virus infection and heart diseases: a multicenter study in Japan. Jpn Circ. J. 1998; 62 (5): 389-391.
- Teragaki M., Nishiguchi S., Takeuchi K. et al. Prevalence of hepatitis C virus infection among patients with hypertrophic cardiomyopathy. Heart and Vessels 2003; 18 (4): 167-170.
- Matsumori A. Hepatitis C virus and cardiomyopathy. Herz 2000; 25 (3): 249-254.
- Matsumori A., Matoba Y., Nishio R. et al. Detection of hepatitis C virus RNA from the heart of patients with hypertrophic cardiomyopathy. Biochem. Biophys. Res. Commun. 1996; 222 (3): 678-682.
- Matsumori A., Ohashi N., Nishio R. et al. Apical hypertrophic cardiomyopathy and hepatitis C infection. Jpn Circ. J. 1999; 63: 433-438.
